Elanco Animal Health Incorporated (ELAN): Price and Financial Metrics


Elanco Animal Health Incorporated (ELAN)

Today's Latest Price: $19.89 USD

0.26 (-1.29%)

Updated Apr 2 2:24pm

Add ELAN to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ELAN Stock Summary

  • With a one year PEG ratio of 1,171.36, Elanco Animal Health Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 97.41% of US stocks.
  • ELAN's went public 1.53 years ago, making it older than just 1.79% of listed US stocks we're tracking.
  • ELAN's current price/earnings ratio is 109.23, which is higher than 96.43% of US stocks with positive earnings.
  • If you're looking for stocks that are quantitatively similar to Elanco Animal Health Inc, a group of peers worth examining would be HOLX, HSTM, OTEX, AGCO, and PRGO.
  • ELAN's SEC filings can be seen here. And to visit Elanco Animal Health Inc's official web site, go to www.elanco.com.
ELAN Daily Price Range
ELAN 52-Week Price Range

ELAN Stock Price Chart More Charts


ELAN Price/Volume Stats

Current price $19.89 52-week high $35.46
Prev. close $20.15 52-week low $15.17
Day low $19.50 Volume 3,137,753
Day high $20.74 Avg. volume 6,581,248
50-day MA $26.50 Dividend yield N/A
200-day MA $28.34 Market Cap 7.93B

Elanco Animal Health Incorporated (ELAN) Company Bio


Elanco Animal Health Incorporated operates as an animal health care company. The Company develops, manufactures, and markets products for companion and food animals. Elanco Animal Health serves clients worldwide. The company is based in Greenfield, Indiana.

ELAN Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$19.89$0.01-100%

We started the process of determining a valid price forecast for Elanco Animal Health Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Elanco Animal Health Inc ranked in the 0th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. The most interesting components of our discounted cash flow analysis for Elanco Animal Health Inc ended up being:

  • The company's compound free cash flow growth rate over the past 1.48 years comes in at -0.62%; that's greater than only 1.3% of US stocks we're applying DCF forecasting to.
  • The company's cost of debt, derived from its interest coverage, tax rate, and market capitalization, is greater than 60.28% of stocks in its sector (Healthcare).


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-100%
1%-100%
2%-100%
3%-100%
4%-100%
5%-100%

ALC, AMPH, CSII, HAPP, and MEDS can be thought of as valuation peers to ELAN, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


ELAN Latest News Stream


Event/TimeNews Detail
Loading, please wait...

ELAN Latest Social Stream


Loading social stream, please wait...

View Full ELAN Social Stream

ELAN Price Returns

1-mo -26.50%
3-mo -31.65%
6-mo -25.73%
1-year -39.42%
3-year N/A
5-year N/A
YTD -32.46%
2019 -6.60%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Continue Researching ELAN

Want to see what other sources are saying about Elanco Animal Health Inc's financials and stock price? Try the links below:

Elanco Animal Health Inc (ELAN) Stock Price | Nasdaq
Elanco Animal Health Inc (ELAN) Stock Quote, History and News - Yahoo Finance
Elanco Animal Health Inc (ELAN) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8152 seconds.